Article Text

Download PDFPDF
Oral Calcium Disodium Versenate in Treatment of Lead Poisoning
  1. J. D. Williams*,
  2. G. A. Matthews,
  3. A. W. Judd
  1. Department of Clinical Pathology, West Herts.
  2. St. Paul's Hospitals, Hemel Hempstead, Herts.


    A clinical trial of oral calcium disodium versenate (E.D.T.A.) in eight lead workers is described. A short course of versenate given while the men continued at work produced no side-effects. Complete overhaul of the processes and protective devices was made in the factory.

    Clinical, biochemical, and haematological improvement followed the removal of up to 250 mg. lead in each case.

    The mode of action and possible uses and abuses of oral versenate are discussed.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


    • * Present address: Department of Pathology, Edgware General Hospital, Edgware, Middlesex.